Dr. Brian Ladle is a pediatric cancer specialist in Baltimore, caring for patients with pediatric sarcoma, neuroblastoma, and other rare solid tumors. In addition to seeing patients, Dr. Ladle leads clinical research studies and his laboratory research program to develop new therapies for pediatric cancers. Dr. Ladle received his undergraduate degree in molecular biology from Brigham Young University. He earned his M.D. and Ph.D. degrees at the Johns Hopkins University School of Medicine. He completed his residency at Cincinnati Children’s Hospital Medical Center and performed a fellowship in pediatric hematology and oncology at Johns Hopkins and the National Institutes of Health. Dr. Ladle joined the Johns Hopkins faculty in 2013. Dr. Ladle's research program focuses on translational immunology, with the goal of developing novel immunotherapies for the treatment of pediatric malignancies. His lab currently focuses on augmenting anti-tumor immune responses to solid tumors such as osteosarcoma, Ewing sarcoma, and rhabdomyosarcoma. He is a member of the American Association for Cancer Research, the American Society for Pediatric Hematology/Oncology, the American Society of Clinical Oncology and the Children's Oncology Group. Dr. Ladle is passionate about ensuring all patients receive cutting-edge, compassionate care as a member of the exceptional care team provided for each pediatric oncology patient and their family.